Author

J. Gao

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Cardiometabolic multimorbidity burden and all-cause mortality after non-ST-segment elevation myocardial infarction: a multi-cohort study

Cardiometabolic multimorbidity (CMM), defined as the coexistence of at least two cardiometabolic diseases (CMDs, including myocardial infarction, diabetes, and stroke), has been established as an important risk factor for adverse cardiovascular outcomes [1-2]. However, the differential impact of varying CMM burde...

J. Gao, Y.-H. Wang, Y.-Q. Li et al. · European Heart Journal · 0 citations

Open access Oct 2026

Association between body mass index and all-cause mortality in patients with non-ST-segment-elevation myocardial infarction

Body mass index (BMI) is a modifiable prognostic factor in non-ST-segment elevation myocardial infarction (NSTEMI). Investigating the impact of BMI on short- and long-term prognosis in patients with NSTEMI can inform clinical management and improve patient outcomes[1, 2]. This study aimed to investigate th...

J. Gao, Y.-Q. Li, Y.-H. Wang et al. · European Heart Journal · 0 citations

Open access Oct 2026

Evolocumab early reduces Interleukin-1β/Interleukin-17A and improves left ventricular function in ST-segment elevation myocardial infarction: an observational study in the real world

While proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) effectively lower low-density lipoprotein cholesterol (LDL-C) levels and reduce the incidence of major adverse cardiovascular events (MACE) in patients with STEMI, the anti-inflammatory effects and impact on early cardiac remodeling of PCSK9i...

J. Gao, M.-L. Zhang, J.-Y. Liu et al. · European Heart Journal · 0 citations